Evaluation of Heparin as a potentially interfering substance [Bioanalytics]

posted by Monic  – India, 2019-09-11 14:04 (444 d 06:56 ago) – Posting: # 20584
Views: 1,943

(edited by Monic on 2019-09-11 14:16)

Hi everyone,

Is it required to evaluate the interaction of "heparin" with your analyte of interest during concomitant medication effect as a part of bio-analytical method validation parameter?
since heparin is infused during blood collection to prevent formation of blood clots in clinical phase.

Note: The anticoagulant used for the blood collection in vacutainer is K2EDTA.

Thanks


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
21,216 posts in 4,427 threads, 1,482 registered users;
online 12 (0 registered, 12 guests [including 12 identified bots]).
Forum time: Saturday 20:00 CET (Europe/Vienna)

Science may be described as the art of systematic over-simplification –
the art of discerning what we may with advantage omit.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5